-transparent.png){kind=logo}
A child, who received successful chemotherapy for pneumoblastoma, developed a myelomonocytic leukemia with translocation t(11;19)(q23;p13) 2 years later. Although this leukemia did not present with features generally associated with therapy-related leukemias, we think this hematologic disease to be secondary to previous chemotherapy. Involvement of chromosome 11q23 is common in acute leukemia and seems to be more significantly related to ANLL in young children (M4 and M5 FAB classification). However, our observation and previous reports suggest that this chromosomal abnormality might be more frequent in therapy-related leukemias. The responsibility of etoposide and cisplatin may be discussed in such secondary malignancies.
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
August 2002,
Cancer genetics and cytogenetics,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
December 1991,
Leukemia,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
November 1986,
Cancer genetics and cytogenetics,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
April 2008,
Pediatric blood & cancer,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
May 1993,
Japanese journal of cancer research : Gann,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
February 1988,
Cancer genetics and cytogenetics,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
October 1986,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
February 1985,
Cancer genetics and cytogenetics,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
July 2015,
Cureus,
X Rialland, and
F Pein, and
J P Saint-Andre, and
F Flamant
December 2001,
International journal of hematology,
